An Experimental Study to Evaluate the Antidepressant Effect of Zileuton and Aqueous Extract of Phyllanthus emblica in Unpredictable Chronic Mild Stress-Induced Depression in Albino Mice

  • 0Pharmacology and Therapeutics, Seth Gordhandas Sunderdas Medical College and King Edward Memorial (KEM) Hospital, Mumbai, IND.

|

|

Summary

This summary is machine-generated.

Zileuton and Phyllanthus emblica show antidepressant effects comparable to fluoxetine by reducing immobility and decreasing neuroinflammation. These findings suggest potential new treatments for depression targeting inflammatory pathways.

Area Of Science

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background

  • Oxidative stress and neuroinflammation play key roles in depression pathogenesis.
  • Targeting these pathways offers potential for novel antidepressant therapies.
  • Zileuton (5-lipoxygenase inhibitor) and Phyllanthus emblica (antioxidant, anti-inflammatory) are investigated for antidepressant properties.

Purpose Of The Study

  • To evaluate the antidepressant activity of zileuton and Phyllanthus emblica extract.
  • To assess their effects on neuroinflammation in a chronic stress mouse model.
  • To compare their efficacy against fluoxetine, a standard antidepressant.

Main Methods

  • A chronic stress mouse model was used to induce depression.
  • Mice were treated with varying doses of zileuton, Phyllanthus emblica, or fluoxetine.
  • Antidepressant effects were measured using tail suspension and forced swim tests.
  • Hippocampal Interleukin-6 (IL-6) levels were quantified.

Main Results

  • Both zileuton and Phyllanthus emblica significantly reduced immobility time in behavioral tests, indicating antidepressant effects.
  • The efficacy of zileuton and Phyllanthus emblica was comparable to fluoxetine.
  • A significant reduction in hippocampal IL-6 levels was observed in treatment groups, suggesting decreased neuroinflammation.

Conclusions

  • Zileuton and Phyllanthus emblica demonstrate antidepressant effects comparable to fluoxetine.
  • The observed antidepressant activity is likely linked to their ability to reduce neuroinflammation.
  • These agents represent promising candidates for depression treatment, particularly for treatment-resistant cases.